Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Biochemistry Biophysics|March 11, 1999
Diagnostic value of ferritin in the differential diagnosis of malignant effusionsA Demirkazik, D Dinçol, S Hastürk, et al.
Medical Oncology (Northwood, London, England)|June 29, 2000
Prevalence of hepatitis-G virus and hepatitis-C virus infection in patients with non-Hodgkin's lymphomaA Arican, T Sengezer, M Bozdayi, et al.
American Journal of Clinical Oncology|December 22, 1999
Clinicopathologic features and prognostic factors of primary extranodal non-Hodgkin's lymphomas in TurkeyA Arican, D Dinçol, H Akbulut, et al.
Oncology|May 27, 1999
Phase II study of cisplatin and dacarbazine for metastatic colorectal carcinoma resistant to 5-fluorouracilF Içli, A Arican, F Cay, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1995
Mesna/ifosfamide, mitoxantrone, etoposide, bleomycin, vincristine, prednisone (MINE-BOP) combination chemotherapy in the treatment of refractory and relapsed non-Hodgkin's lymphomaD Dinçol, F Içli, H Karaoğuz, et al.
Sarcoma|June 4, 2008
The clinical value of flow cytometric DNA content analysis in patients with soft tissue sarcomasM Samur, A Pamir, H Akbulut, et al.
Lung Cancer (Amsterdam, Netherlands)|September 1, 1996
Two dose levels of ifosfamide in malignant mesotheliomaF Içli, H Karaoğuz, S Hastürk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
A randomized trial of four cycles of adjuvant AC (adriamycin + cyclophosphamide) +/- two cycles of EP (etoposide + cisplatin) in node positive patients with breast cancerF Içli, H Akbulut, D Dinçol, et al.
Cancer|May 17, 2000
Prospective randomized comparison of morning versus night daily single subcutaneous administration of granulocyte-macrophage-colony stimulating factor in patients with soft tissue or bone sarcomaD Dinçol, M Samur, A Pamir, et al.
Pageof 2